This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "October Pharmacy WGM Agenda"

From HL7Wiki
Jump to navigation Jump to search
 
(3 intermediate revisions by the same user not shown)
Line 79: Line 79:
 
* Status of 2 outstanding ballots for publication
 
* Status of 2 outstanding ballots for publication
 
* Review outstanding FHIR GForge tracker items
 
* Review outstanding FHIR GForge tracker items
−
||Marla available||Melva||TBD
+
||Scott||Melva||TBD
 
|-
 
|-
 
||Q2||[[Image:Technical_med.gif|24px]]||Committee Meeting - Joint with FHIR<br>
 
||Q2||[[Image:Technical_med.gif|24px]]||Committee Meeting - Joint with FHIR<br>
Line 85: Line 85:
 
* Modeling resources needed
 
* Modeling resources needed
 
* FHIR resources needed
 
* FHIR resources needed
−
* Pharmacy examples
+
* Pharmacy examples - can these be included as part of 2.1?
−
||Melva, Marla||||TBD
+
||Scott||Melva|||TBD
 
|-
 
|-
 
| rowspan="2" align="middle" |PM  
 
| rowspan="2" align="middle" |PM  
 
||Q3||[[Image:Technical_med.gif|24px]]||Committee Meeting<br>
 
||Q3||[[Image:Technical_med.gif|24px]]||Committee Meeting<br>
 
* Prepare for meeting SDWG resources - Wed Q3
 
* Prepare for meeting SDWG resources - Wed Q3
 +
** Is there a clear way to identify brand vs generic since they are all send in the code element? Or is the general recommendation to not send brand-equivalent or generic-equivalent codes in medications?
 +
**Approach for expressing drug classes
 +
** Quick review and update to matrix of medication scenarios and representation details
 +
** Discuss use of list resource and mapping to C-CDA (did this previously, but think it wouldn’t hurt to review again)
 
* Pharmacy Glossary Project - Discussion
 
* Pharmacy Glossary Project - Discussion
 
* Discussion of Pharmacy Webinar - Discussion
 
* Discussion of Pharmacy Webinar - Discussion
 
* Action Item List
 
* Action Item List
 
* Pharmacy FHIR Work
 
* Pharmacy FHIR Work
−
* Is there a clear way to identify brand vs generic since they are all send in the code element? Or is the general recommendation to not send brand-equivalent or generic-equivalent codes in medications?
+
||Melva||Marla||TBD
−
* Approach for expressing drug classes
 
−
* Quick review and update to matrix of medication scenarios and representation details
 
−
* Discuss use of list resource and mapping to C-CDA (did this previously, but think it wouldn’t hurt to review again)
 
−
 
 
−
||Melva, Marla available||TBD||TBD
 
 
|-
 
|-
 
||Q4||[[Image:Technical_med.gif|24px]]||Joint with PHER (PHER hosting) (John H will attend) <br>
 
||Q4||[[Image:Technical_med.gif|24px]]||Joint with PHER (PHER hosting) (John H will attend) <br>
Line 119: Line 118:
 
** 3 year plan review
 
** 3 year plan review
 
** Action Item list review
 
** Action Item list review
−
* Discussion of joint meeting with ISO and IHE
+
* Discussion of joint meeting with ISO and IHE - Michael Tan is joining
 
* Pharmacy FHIR Work
 
* Pharmacy FHIR Work
−
||Marla available||Melva||TBD
+
||Marla||Melva||TBD
 
|-
 
|-
 
||Q2||[[Image:Technical_med.gif|24px]]||Committee Meeting<br>
 
||Q2||[[Image:Technical_med.gif|24px]]||Committee Meeting<br>
 
* Pharmacy Template Work (Kai)
 
* Pharmacy Template Work (Kai)
−
||Marla available||TBD||TBD
+
||Melva||John||TBD
 
|-
 
|-
 
| rowspan="2" align="middle" |PM  
 
| rowspan="2" align="middle" |PM  
Line 134: Line 133:
 
* Quick review and update to matrix of medication scenarios and representation details  
 
* Quick review and update to matrix of medication scenarios and representation details  
 
* Discuss use of list resource and mapping to C-CDA (did this previously, but think it wouldn’t hurt to review again)
 
* Discuss use of list resource and mapping to C-CDA (did this previously, but think it wouldn’t hurt to review again)
−
||Melva, Marla available||TBD||TBD
+
||Melva||Marla||TBD
 
|-
 
|-
 
||Q4||[[Image:Technical_med.gif|24px]]||Joint Meeting with Patient Care - Pt Care Hosting
 
||Q4||[[Image:Technical_med.gif|24px]]||Joint Meeting with Patient Care - Pt Care Hosting
Line 151: Line 150:
 
** http://gforge.hl7.org/gf/project/fhir/tracker/?action=TrackerItemEdit&tracker_item_id=8689&start=0
 
** http://gforge.hl7.org/gf/project/fhir/tracker/?action=TrackerItemEdit&tracker_item_id=8689&start=0
 
** http://gforge.hl7.org/gf/project/fhir/tracker/?action=TrackerItemEdit&tracker_item_id=8688&start=0
 
** http://gforge.hl7.org/gf/project/fhir/tracker/?action=TrackerItemEdit&tracker_item_id=8688&start=0
−
||Marla available||TBD||TBD
+
||Marla||Scott||TBD
 
|-
 
|-
 
||Q2||[[Image:Technical_med.gif|24px]]||Committee Meeting<br>
 
||Q2||[[Image:Technical_med.gif|24px]]||Committee Meeting<br>
 
* Pharmacy FHIR Work
 
* Pharmacy FHIR Work
−
||Marla available||TBD||TBD
+
||John||Marla||TBD
 
|-
 
|-
 
| rowspan="2" align="middle" |PM  
 
| rowspan="2" align="middle" |PM  
 
||Q3||[[Image:Technical_med.gif|24px]]||Committee Meeting <br>
 
||Q3||[[Image:Technical_med.gif|24px]]||Committee Meeting <br>
 
* Pharmacy FHIR Work
 
* Pharmacy FHIR Work
−
||Marla available||TBD||TBD
+
||Marla||John||TBD
 
|-
 
|-
 
||Q4||[[Image:Technical_med.gif|24px]]||Committee Meeting <br>
 
||Q4||[[Image:Technical_med.gif|24px]]||Committee Meeting <br>
 
* Pharmacy FHIR Work
 
* Pharmacy FHIR Work
−
||Marla available||TBD||TBD
+
||John||Marla||TBD
 
|-border="4" cellpadding="8" style="background:#f0f0f0;"
 
|-border="4" cellpadding="8" style="background:#f0f0f0;"
 
|. |||||||||||||||||
 
|. |||||||||||||||||

Latest revision as of 14:17, 6 October 2015

Contents

Related Links

Agenda

Day Date ' Time Icon Event Chair Scribe Room
Sunday October 4, 2015 AM Q1 Technical med.gif Pharmacy WG Not Meeting NA NA NA
Q2 Technical med.gif Pharmacy WG Not Meeting NA NA NA
PM Q3 Technical med.gif Pharmacy WG Not Meeting NA NA NA
Q4 Technical med.gif Pharmacy WG Not Meeting NA NA NA
.
Monday October 5, 2015 AM Q1 Technical med.gif Pharmacy WG Not Meeting NA NA NA
Q2 Technical med.gif Pharmacy WG Not Meeting NA NA NA
PM Q3 Technical med.gif Joint meeting with O&O - O&O hosting NA
Melva, Marla not available		 NA TBD
Q4 Technical med.gif Joint meeting with O&O - O&O hosting NA
Melva, Marla not available		 NA TBD
.
Tuesday October 6, 2015 AM Q1 Technical med.gif Committee Meeting
  • Finalize agenda
  • Reps to other WG
  • Assign roles for Quarters
  • If we have new attendees, review
    • Overview of Pharmacy material - V2, V3, FHIR resources
    • Overview of Pharmacy template work
  • Hot Topics
  • Status of 2 outstanding ballots for publication
  • Review outstanding FHIR GForge tracker items
 Scott Melva TBD
Q2 Technical med.gif Committee Meeting - Joint with FHIR
  • Pharmacy FHIR work
  • Modeling resources needed
  • FHIR resources needed
  • Pharmacy examples - can these be included as part of 2.1?
 Scott Melva TBD
PM Q3 Technical med.gif Committee Meeting
  • Prepare for meeting SDWG resources - Wed Q3
    • Is there a clear way to identify brand vs generic since they are all send in the code element? Or is the general recommendation to not send brand-equivalent or generic-equivalent codes in medications?
    • Approach for expressing drug classes
    • Quick review and update to matrix of medication scenarios and representation details
    • Discuss use of list resource and mapping to C-CDA (did this previously, but think it wouldn’t hurt to review again)
  • Pharmacy Glossary Project - Discussion
  • Discussion of Pharmacy Webinar - Discussion
  • Action Item List
  • Pharmacy FHIR Work
 Melva Marla TBD
Q4 Technical med.gif Joint with PHER (PHER hosting) (John H will attend)
  • TBD
 NA NA TBD
.
Wednesday October 7, 2015 AM Q1 Technical med.gif Committee Meeting
  • Approval for January 2016 WGM Minutes
  • Schedule for Conference calls
  • Forward Planning
    • Project Review
    • 3 year plan review
    • Action Item list review
  • Discussion of joint meeting with ISO and IHE - Michael Tan is joining
  • Pharmacy FHIR Work
 Marla Melva TBD
Q2 Technical med.gif Committee Meeting
  • Pharmacy Template Work (Kai)
 Melva John TBD
PM Q3 Technical med.gif Committee Meeting
  • Joint topics with SDWG
  • Is there a clear way to identify brand vs generic since they are all send in the code element? Or is the general recommendation to not send brand-equivalent or generic-equivalent codes in medications?
  • Approach for expressing drug classes
  • Quick review and update to matrix of medication scenarios and representation details
  • Discuss use of list resource and mapping to C-CDA (did this previously, but think it wouldn’t hurt to review again)
 Melva Marla TBD
Q4 Technical med.gif Joint Meeting with Patient Care - Pt Care Hosting NA NA TBD
.
Thursday October 8, 2015 AM Q1 Technical med.gif Committee Meeting
Marla Scott TBD
Q2 Technical med.gif Committee Meeting
  • Pharmacy FHIR Work
 John Marla TBD
PM Q3 Technical med.gif Committee Meeting
  • Pharmacy FHIR Work
 Marla John TBD
Q4 Technical med.gif Committee Meeting
  • Pharmacy FHIR Work
 John Marla TBD
.
Friday October 9, 2015 AM Q1 Technical med.gif Pharmacy WG Not Meeting NA NA NA
Q2 Technical med.gif Pharmacy WG Not Meeting NA NA NA
PM Q3 Technical med.gif Pharmacy WG Not Meeting NA NA NA
Q4 Technical med.gif Pharmacy WG Not Meeting NA NA NA
.

Icons:

  • Ballot Reconciliation meeting Reconciliation med.gif
  • Work Group technical discussion Technical med.gif
Retrieved from "https://wiki.hl7.org/w/index.php?title=October_Pharmacy_WGM_Agenda&oldid=105154"